Furazolidone-containing triple and quadruple eradication therapy for initial treatment for Helicobacter pylori infection: A multicenter randomized controlled trial in China.
Yong XieZhenyu ZhangJunbo HongWenzhong LiuHong LuYiqi DuWeihong WangJianming XuXuehong WangLijuan HuoGuiying ZhangChunhui LanXiaoyan LiYanqing LiHong WangGuoxin ZhangYin ZhuXu ShuYe ChenJiangbin WangNong Hua Lunull nullPublished in: Helicobacter (2018)
Furazolidone-containing therapies, particularly the tested 10-day quadruple therapy, exhibited satisfactory efficacy and safety. This 10-day quadruple therapy represents a promising initial treatment strategy for Chinese patients.